Full-Life Technologies
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing
$150MSeries D+Debt
Role not disclosedSB
SK Biopharmaceuticals Co. Ltd.
Activity from announced rounds
Activity in this selectionj-p-morgan-life-sciences-private-capital-2d7805a5
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $150M 1 disclosed · full round size, not this investor’s share